In vitro modeling of amyotrophic lateral sclerosis with induced pluripotent stem cell technology-derived cell line ORIONi002-A


We present here a new iPS cell line for modeling sporadic form of ALS. Cell line was generated by reprogramming skin fibroblasts isolated with explant culture technology from skin biopsy, donated by ALS patient. For reprogramming, polycistronic self-replicating RNA vector was used and derived iPS cells were characterized by immunocytochemistry and FACS (pluripotent factors expression), karyotyping, STR fingerprinting analysis and in vitro differentiation assay. New cell line showed normal (46, XY) karyotype and differentiated in vitro into cells from three germ layers. STR analysis proved the origin and originality of the cell line. Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Authors Strnadel J, Dumortier HM, Hajduchova D, Zahumenska R, Nosal V, Smolar M, Marcinek J, Kalman M, Mersakova S, Brany D, Juhas S, Juhasova J, Studenovska H, Mitruskova B, Suroviakova S, Novakova S, Skovierova H, Kurca E, Pecova R, Plank L, Halasova E
Journal Stem cell research
Publication Date 2022 Aug;63:102870
PubMed 35907349
DOI 10.1016/j.scr.2022.102870

Research Projects

Cell Lines